Record Details

BMI and adipocytokine changes in COPD exacerbation and stable COPD

NOPR - NISCAIR Online Periodicals Repository

View Archive Info
 
 
Field Value
 
Title BMI and adipocytokine changes in COPD exacerbation and stable COPD
 
Creator Cambay, Zafer
Ilhan, Nevin
Susam, Solmaz
Muz, Mehmet Hamdi
 
Subject Adiponectin
Chronic obstructive pulmonary disease (COPD)
Interleukin-6
Malondialdehyde (MDA)
Visfatin
 
Description 472-477
COPD is described by progressive airflow restriction and recurrent acute exacerbations, which is caused by inflammatory response occurring in lungs as a result of chronic inhalation of harmful particles and gases. The study was designed to determine the link of interleukin-6 (IL-6), adiponectin and visfatin with BMI and oxidant/antioxidant balance in Chronic Obstructive Pulmonary Disease (COPD), a systemic disease. The study comprised control (n=20), patients with COPD (n=37) from the Chest Diseases Clinic of Firat University Hospital. The serum MDA, IL-6, Visfatin and Adiponectin levels were evaluated by ELISA. Also, Pulmonary Function Tests were done. There was no significant difference between control and patients with COPD in terms of sex and age averages. On the contrary, BMI levels were statistically significantly lower in COPD group compared to the controls. MDA and adiponectin levels were higher, IL-6 and visfatin levels were lower in COPD groups contrary to controls. It was thought that the level changes of these parameters (MDA, IL-6, visfatin and adiponectin) may be an important factor in the development of COPD and in monitoring the treatment of COPD-related diseases.
 
Date 2021-10-06T06:17:51Z
2021-10-06T06:17:51Z
2021-10
 
Type Article
 
Identifier 0975-0959 (Online); 0301-1208 (Print)
http://nopr.niscair.res.in/handle/123456789/58238
 
Language en
 
Publisher NIScPR-CSIR, India
 
Source IJBB Vol.58(5) [October 2021]